Literature DB >> 8506352

The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development.

M Goedert1, R Jakes, R A Crowther, J Six, U Lübke, M Vandermeeren, P Cras, J Q Trojanowski, V M Lee.   

Abstract

Tau is a neuronal phosphoprotein whose expression is developmentally regulated. A single tau isoform is expressed in fetal human brain but six isoforms are expressed in adult brain, with the fetal isoform corresponding to the shortest of the adult isoforms. Phosphorylation of tau is also developmentally regulated, as fetal tau is phosphorylated at more sites than adult tau. In Alzheimer disease, the six adult tau isoforms become abnormally phosphorylated and form the paired helical filament, the major fibrous component of the characteristic neurofibrillary lesions. We show here that Ser-202 (in the numbering of the longest human brain tau isoform) is a phosphorylation site that distinguishes fetal from adult tau and we identify it as one of the abnormal phosphorylation sites in Alzheimer disease. The abnormal phosphorylation of tau at Ser-202 in Alzheimer disease thus recapitulates normal phosphorylation during development.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8506352      PMCID: PMC46655          DOI: 10.1073/pnas.90.11.5066

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Two novel kinases phosphorylate tau and the KSP site of heavy neurofilament subunits in high stoichiometric ratios.

Authors:  H M Roder; V M Ingram
Journal:  J Neurosci       Date:  1991-11       Impact factor: 6.167

2.  The microtubule binding domain of tau protein.

Authors:  G Lee; R L Neve; K S Kosik
Journal:  Neuron       Date:  1989-06       Impact factor: 17.173

3.  A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis.

Authors:  S G Greenberg; P Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 4.  Molecular characterization of microtubule-associated proteins tau and MAP2.

Authors:  M Goedert; R A Crowther; C C Garner
Journal:  Trends Neurosci       Date:  1991-05       Impact factor: 13.837

5.  Structural stability of paired helical filaments requires microtubule-binding domains of tau: a model for self-association.

Authors:  H Ksiezak-Reding; S H Yen
Journal:  Neuron       Date:  1991-05       Impact factor: 17.173

6.  Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms.

Authors:  M Goedert; M G Spillantini; N J Cairns; R A Crowther
Journal:  Neuron       Date:  1992-01       Impact factor: 17.173

7.  Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau.

Authors:  S G Greenberg; P Davies; J D Schein; L I Binder
Journal:  J Biol Chem       Date:  1992-01-05       Impact factor: 5.157

8.  A68: a major subunit of paired helical filaments and derivatized forms of normal Tau.

Authors:  V M Lee; B J Balin; L Otvos; J Q Trojanowski
Journal:  Science       Date:  1991-02-08       Impact factor: 47.728

9.  Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization.

Authors:  M Goedert; R Jakes
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

10.  Tau protein binds to microtubules through a flexible array of distributed weak sites.

Authors:  K A Butner; M W Kirschner
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

View more
  111 in total

1.  Both total and phosphorylated tau are increased in Alzheimer's disease.

Authors:  M Sjögren; P Davidsson; M Tullberg; L Minthon; A Wallin; C Wikkelso; A K Granérus; H Vanderstichele; E Vanmechelen; K Blennow
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-05       Impact factor: 10.154

Review 2.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

3.  Hyperactivation of mitogen-activated protein kinase increases phospho-tau immunoreactivity within human neuroblastoma: additive and synergistic influence of alteration of additional kinase activities.

Authors:  F J Ekinci; T B Shea
Journal:  Cell Mol Neurobiol       Date:  1999-04       Impact factor: 5.046

4.  Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons.

Authors:  S E Merrick; J Q Trojanowski; V M Lee
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

5.  Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death.

Authors:  C Stadelmann; T L Deckwerth; A Srinivasan; C Bancher; W Brück; K Jellinger; H Lassmann
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

Review 6.  Human fetal tau protein isoform: possibilities for Alzheimer's disease treatment.

Authors:  Nataša Jovanov-Milošević; Davor Petrović; Goran Sedmak; Mario Vukšić; Patrick R Hof; Goran Simić
Journal:  Int J Biochem Cell Biol       Date:  2012-05-15       Impact factor: 5.085

7.  Flavanols, mild cognitive impairment, and Alzheimer's dementia.

Authors:  Ami K Patel; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Med       Date:  2008-04-15

8.  The role of tau phosphorylation in transfected COS-1 cells.

Authors:  M Medina; E Montejo de Garcini; J Avila
Journal:  Mol Cell Biochem       Date:  1995-07-05       Impact factor: 3.396

9.  Stress-induced tau phosphorylation in mouse strains with different brain Erk 1 + 2 immunoreactivity.

Authors:  A Y Korneyev
Journal:  Neurochem Res       Date:  1998-12       Impact factor: 3.996

10.  Modifications of tau protein after cerebral ischemia and reperfusion in rats are similar to those occurring in Alzheimer's disease - Hyperphosphorylation and cleavage of 4- and 3-repeat tau.

Authors:  Hiroki Fujii; Tetsuya Takahashi; Tomoya Mukai; Shigeru Tanaka; Naohisa Hosomi; Hirofumi Maruyama; Norio Sakai; Masayasu Matsumoto
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.